The introduction of nicotinamide being a nicotine alternative in e-cigarette and smokeless products signifies an important regulatory challenge for the FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to work as a sedative at large dosages6. The statements produced by Nicotine River, ECBlend, and also other suppl